Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04704089
Other study ID # APHP190001
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 18, 2022
Est. completion date April 18, 2025

Study information

Verified date May 2024
Source Assistance Publique - Hôpitaux de Paris
Contact Sophia HOUARI, MCU-PH
Phone 06 12 16 88 35
Email sophia.houari@aphp.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study focuses on the analysis of enamel defects grouping together hypomineralization and hypoplasia. It focuses on 3 very characteristic enamel pathologies that are most often encountered in dental consultations: Molar Incisor Hypomineralization (MIH), dental fluorosis (FD) and amelogenesis imperfecta (AI). The research focuses on the use of a spectrophotometer for measuring tooth colors: the Zfx SpectroShade® (MHT) and its software as a means of early diagnosis of pre-eruptive enamel abnormalities. The main objective of the study is to analyze the color parameters of teeth affected with one of the 3 enamel abnormalities for use of the spectrophotometer as a non-invasive diagnostic tool for enamel defects. The secondary objective is focused on the biological, structural and physicochemical characterizations of these different enamel pathologies from extracted teeth or enamel biopsies that must be ground to achieve a restoration.


Description:

Methodology: V1 inclusion visit (D1): The subjects will be screened during a consultation carried out as part of the treatment in the participating dentistry departments. The inclusion and non-inclusion criteria for participants will be verified and the study will be offered to eligible patients and controls. The research briefing note will be given and the non-objection of the participants (adults and representative (s) of parental authority) will be collected. The investigator will then take the photographs and spectrophotometer shots (at least 2 teeth per participant). V2 follow-up visit (within 2 months of the inclusion visit (D2 to M2)): The patients will be reviewed in consultation as part of the treatment for selective grinding for dental restoration or extraction (if the tooth (s) is (are) no longer storable). The teeth or pathological enamel samples will be recovered and centralized at the Laboratory of Oral Molecular Physiopathology. Biological, structural and physico-chemical analyzes will be carried out from these samples. In order to ensure follow-up of participants, the principal investigator of each center will maintain a correspondence table including the participant's identity and his research identification number. He will also keep a register of oppositions up to date. The subject's opposition or participation will be notified in his medical file. A copy of the briefing notes and non-objection forms signed by the dentist will be kept on site with the research documents. Minors who become adults during their participation will benefit from appropriate information and their non-objection will be collected. Primary endpoint Analysis, using the spectrophotometer, of the numerical values of the color of the teeth in each of the populations studied (Hereditary amelogenesis imperfecta (AIH), dental fluorosis (FD), Hypomineralization Incisors and Molar (MIH) and control). For each pathology, the values of these parameters will be compared. Secondary endpoints - Intra-pathology classification according to the severity of each pathology. - Characterization and biological, structural and physicochemical analysis of these different pathologies from extracted teeth or enamel biopsy to be ground to achieve a restoration. Sample analysis The teeth samples will be stored at room temperature in the Oral Molecular Physiopathology laboratory in the Research Center. During the research, biological, structural and physicochemical analyzes will be carried out at the laboratory or in another laboratory in France or abroad. A contract will be established upstream of these analyzes with the partner laboratory. At the end of the research, samples not destroyed by destructive analysis techniques will be embedded in the resin and stored for 10 years before being destroyed. These samples can be used for additional analyzes (biological, structural and physico-chemical) according to the request of the references for the publication process.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date April 18, 2025
Est. primary completion date April 18, 2025
Accepts healthy volunteers No
Gender All
Age group 8 Years to 55 Years
Eligibility For patients : Inclusion Criteria : 1. Age between 8 and 55 years old 2. Carrier of one of the following 3 quantitative pre-eruptive enamel anomalies : AIH, dental fluorosis or MIH 3. Information and collection of the non-opposition of the adult patient or of the representative(s) of parental authority present for the minors. Criteria for non-inclusion : 1. Pregnant or breastfeeding woman 2. Under guardianship or curators 3. Opposition of the minor patient 4. Presenting pre-eruptive anomalies only on the molars (the spectrophotometer can only take pictures of the anterior dental sector (incisors and canines)). 5. Other types of hypomineralization (post-eruptive, of traumatic or infectious origin, idiopathic). 6. Having undergone radiotherapy or chemotherapy inducing dental and periodontal damage. 7. Having systemic abnormalities (unbalanced diseases), haemochromatosis, porphyria 8. Under medication likely to disturb the coloring of the teeth For witnesses : Inclusion Criteria : 1. Age between 8 and 55 years old 2. Information and collection of the non-opposition of the adult witness or of the representative(s) of parental authority present for the minors. 3. Free of any anomaly of tooth structure, exogenous dyschromia and carious lesions. Criteria for non-inclusion : 1. Pregnant or breastfeeding woman 2. Under guardianship or curators 3. Opposition of the minor witness 4. Carrier of a quantitative pre-eruptive enamel anomaly 5. Polycarpus (preventing the diagnosis of amyl hypomineralization)

Study Design


Intervention

Other:
spectrophotometer
Calibration of the spectrophotometer (calibration of white and green color on the provided support), Placing the patient or witness in the chair, Placement of intraoral retractors, Photographs of the dental arch in occlusion as well as slightly open mouth to visualize the mandibular incisors, If MIH is suspected, occlusal images of the occlusal surfaces of the first molars will be taken with the help of a dental mirror, Shooting with the spectrophotometer centered on each of the teeth of interest in the anterior sector with verification of the good quality of the shot according to the axis (validated in green on the camera), Backup of images with coded identification number
Biological (protein analysis by western blot or mass spectrometry of matrix proteins), structural (electron microscopy) and physico-chemical analyses
Chemical analysis of enamel mineral. Techniques of spectrometry and spectroscopy (Raman and FTIR) Atomic Probe Tomography and Protein Mass Spectrometry (ICP-MS).

Locations

Country Name City State
France Service d'odontologie, Hôpital Pitié-Salpêtrière Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary analyze the color parameters of teeth presenting one of the 3 enamel anomalies in order to use the spectrophotometer as a non-invasive diagnostic tool for enamel dyschromia. at the first visit = inclusion visit
Secondary Biological characterization of the proteins of the dental enamel matrix by Western Blot and/or mass spectrometry from samples (extracted teeth or enamel biopsies to be ground during the treatment). at the second visit, 2 months after inclusion visit and after tooth extraction
Secondary Ultra-structural characterization under electron microscope and biomechanics by nanoindentation of enamel pathologies from extracted teeth or enamel biopsies to be ground during the treatment. at the second visit, 2 months after inclusion visit and after tooth extraction
Secondary Physico-chemical characterization by different spectroscopic techniques of enamel pathologies from extracted teeth or enamel biopsies to be ground during the treatment. at the second visit, 2 months after inclusion visit and after tooth extraction
Secondary Physico-chemical characterization by atomic probe tomography of enamel pathologies from extracted teeth or enamel biopsies to be ground during the treatment. at the second visit, 2 months after inclusion visit and after tooth extraction
See also
  Status Clinical Trial Phase
Recruiting NCT04927962 - Psycho-social Impact of Amelogenesis and Dentinogenesis Imperfecta
Active, not recruiting NCT04897724 - Clinical Performance of Composites in Patients With Amelogenesis Imperfecta N/A
Active, not recruiting NCT03810859 - Non-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants N/A
Terminated NCT01746121 - Amelogenesis Imperfecta
Recruiting NCT05343247 - Dental Age Estimation by Different Methods in Patients With Amelogenesis Imperfecta
Not yet recruiting NCT02994862 - E. Max Laminate Veneers With and Without Using Galla Chinnesis as Natural Cross Linking and Remineralizing Agent N/A